Biomea Fusion Announces Proposed Public Offering of Securities
SAN CARLOS, Calif., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity...
Morning Movers
Biomea Fusion Announces Positive 52-Week Results from Phase II COVALENT-111 Study in Type 2 Diabetes Demonstrating Non-Chronic Treatment with Icovamenib Benefits Two Distinct Patient Populations
Icovamenib showed a sustained treatment benefit at Week 52 (9 months past the end of treatment) in the severe insulin-deficient...
Immix Biopharma to Present Abstract at the upcoming ASH 2025 Annual Meeting
Los Angeles, CA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the...
Serve Robotics Deploys 1,000th Autonomous Delivery Robot
SAN FRANCISCO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Serve Robotics Inc. (Nasdaq: SERV), a leading autonomous sidewalk delivery company, today...
Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
PHILADELPHIA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company...
Applied DNA Sciences to Begin Trading Under New Ticker ‘BNBX’ Reflecting Digital Asset Treasury Strategy
STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a biotechnology company advancing a yield...
Marker Therapeutics Announces First Patient Treated in Off-the-Shelf Program
Marker Therapeutics initiated Phase 1 RAPID study to investigate Multi-Antigen Recognizing (MAR) T cells as an Off-the-Shelf (OTS) product to...
Humacyte Announces Publication of Long-Term Results for Ukrainian Patients Treated in Real-World Combat Setting with Symvess™
- Results published in Oxford Academic’s Military Medicine Journal - - After up to 18 months of follow-up patients were...
Fannie Mae Announces Results of Tender Offer for Any and All of Certain CAS Notes
WASHINGTON, Oct. 6, 2025 /PRNewswire/ -- Fannie Mae (OTCQB: FNMA) today announced the results of its fixed-price cash tender offers (each,...
Syntec Optics Holdings, Inc. (Nasdaq: OPTX) Reports Full Year 2024 and First Half 2025 Financial Results
ROCHESTER, NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (“Syntec Optics” or the “Company”) (Nasdaq: OPTX),...
Gain Therapeutics Presents Initial Data from Phase 1b Clinical Study of GT-02287 in Parkinson’s Patients at International Congress of Parkinson’s Disease and Movement Disorders®
Improvement observed in MDS-UPDRS scores in first 9 participants enrolled; 90-day follow-up continuing in remaining participants Plasma exposures in patients...
URANIUM ENERGY CORP ANNOUNCES THE CLOSING OF $203 MILLION PUBLIC OFFERING
NYSE American: UEC Proceeds to be Used to Accelerate the Development of the United States Uranium Refining & Conversion Corp CORPUS CHRISTI, Texas,...
Blackbaud Unveils Seismic Shifts in AI Innovation, Rolling Out 70+ Embedded, Sector-Specific Capabilities and Unlocking New Possibility for Social Impact
Bold New Initiatives and Connected Intelligent Systems Aim to Make the Artificial Intelligence Promise Real for the Organizations Tackling the...
Airship AI Announces $11.0 Million of Firm Fixed Price Brand Name Only Awards from US Federal Law Enforcement Agencies in September
Public Safety and Homeland Security Macro Tailwinds Remain Strong Heading into the US Federal Government’s Fiscal First Quarter REDMOND, Wash.,...
RETRANSMISSION: HIVE Digital Technologies September Bitcoin Production at 267 BTC, Climbs 8% MoM and 138% YoY, Surpassing 21 EH/s and Now Producing 9 BTC Per Day
This news release constitutes a "designated news release for the purposes of the Company's amended and restated prospectus supplement dated...
HIVE Digital Technologies September Bitcoin Production at 267 BTC, Climbs 8% MoM and 138% YoY, Surpassing 21 EH/s and Now Producing 9 BTC Per Day
This news release constitutes a "designated news release for the purposes of the Company's amended and restated prospectus supplement dated...
Invivyd Announces U.S. IND Clearance and Alignment with U.S. FDA on Pivotal Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
The DECLARATION (safety and efficacy vs. placebo) and LIBERTY (exploratory safety head-to-head and combination with mRNA-based COVID vaccination) clinical trials...
AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.
Eligible Patients Can Access Repatha at Nearly 60% Discount From the List Price THOUSAND OAKS, Calif., Oct. 6, 2025 /PRNewswire/...
Graphite One Welcomes Strategic Investment from Doyon Limited and Aleut
Doyon and Aleut have made an investment totaling US$5.0 million in Graphite One, fully supporting the development of the Graphite...
Construction Partners, Inc. Completes Texas Acquisition
Company Adds Eight Hot-Mix Asphalt Plants in Houston Metro Area DOTHAN, Ala., Oct. 6, 2025 /PRNewswire/ -- Construction Partners, Inc....
Avidity Biosciences to Present Data from EXPLORE44® Clinical Development Program of Del-Zota in DMD44 at 30th Annual Congress of the World Muscle Society
SAN DIEGO, Oct. 6, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new...
QYOU Media Subsidiary Chatterbox Technologies Completes Successful India IPO
Oversubscribed Issue Drives 17% Two Day Gain From Top End of Initial Pricing Over 2.1M Shares Traded Representing Buying of...
FedEx Announces Marshall Witt as Senior Vice President and Chief Financial Officer of FedEx Freight
MEMPHIS, Tenn.--(BUSINESS WIRE)--FedEx Corp. (NYSE: FDX) today announced that Marshall Witt, formerly the chief financial officer of TD SYNNEX, a...
NexPoint Residential Trust, Inc. Announces Third Quarter 2025 Earnings Conference Call
DALLAS, Oct. 6, 2025 /PRNewswire/ -- NexPoint Residential Trust, Inc. ("NXRT" or the "Company") (NYSE: NXRT) announced today that the...
NexPoint Real Estate Finance, Inc. Announces Third Quarter 2025 Earnings Conference Call
DALLAS, Oct. 6, 2025 /PRNewswire/ -- NexPoint Real Estate Finance, Inc. (NYSE: NREF) (the "Company") announced today that the Company...
Neurocrine Biosciences Presents New Three-Year Data Demonstrating Sustained Clinical Benefits and Established Safety Profile of INGREZZA® (valbenazine) Capsules for Huntington’s Disease Chorea
Once-daily INGREZZA treatment was generally well tolerated and showed early and sustained improvements in chorea severity Findings presented at 2025...
TC Energy announces consideration of U.S. Junior Subordinated Notes Offering by TransCanada PipeLines Limited
CALGARY, Alberta, Oct. 06, 2025 (GLOBE NEWSWIRE) -- News Release – TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or...
Atossa Therapeutics Streamlines EVANGELINE Breast Cancer Clinical Trial to Prioritize for 2026 NDA-Enabling Activities
Changes are expected to reduce future study costs, accelerate objective readouts, and extend operating runway under current plans SEATTLE, Oct....
Spruce Biosciences Receives U.S. FDA Breakthrough Therapy Designation for Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) in Sanfilippo Syndrome Type B (MPS IIIB)
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies...
TransDigm Completes Acquisition of the Simmonds Precision Products, Inc. Business of Goodrich Corporation from RTX Corporation
CLEVELAND, Oct. 6, 2025 /PRNewswire/ -- TransDigm Group Incorporated ("TransDigm Group") (NYSE: TDG) today announced that it has successfully completed...
Pixelworks Announces $7 Million Registered Direct Offering
PORTLAND, Ore., Oct. 6, 2025 /PRNewswire/ -- Pixelworks, Inc. (NASDAQ: PXLW), a leading provider of innovative video and display processing solutions,...
DarioHealth and OneStep Announce Strategic Collaboration to Integrate Smartphone-Only, Clinical-Grade Fall Risk Assessment Technology into Dario’s Digital Health Multi-Condition Platform
Collaboration designed to drive measurable return on investment ("ROI") for health plans by reducing falls and improving outcomes for high-risk...
Oracle AI Agents Help Marketing, Sales, and Service Leaders Unlock New Revenue Opportunities
New role-based AI agents embedded in Oracle Fusion Cloud Applications help organizations efficiently enhance customer experiences AUSTIN, Texas, Oct. 6, 2025...
Critical Metals Corp Signs $35 million PIPE With a New Fundamental Institutional Investor
NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a...
WESTERN COPPER AND GOLD ANNOUNCES SUBMISSION OF ESE STATEMENT
VANCOUVER, BC, Oct. 6, 2025 /PRNewswire/ - Western Copper and Gold Corporation ("Western" or the "Company") (TSX: WRN) (NYSE American:...
Bitcoin Depot Enhances Leading Compliance Program with ID Verification and Senior Protections
ATLANTA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Bitcoin Depot (“Bitcoin Depot” or the “Company”) (NASDAQ: BTM), a U.S.-based Bitcoin ATM...
Boqii Holding Limited Provides Response to Unusual Market Action
SHANGHAI, Oct. 6, 2025 /PRNewswire/ -- Boqii Holding Limited ("Boqii" or the "Company") (NYSE American: BQ), a leading pet-focused platform...
Innovative Eyewear Reports Strong International Expansion at SILMO Paris 2025, Securing Key European Distribution Partners
Company Showcased at SILMO's Inaugural Smart Eyewear Tech Village, Announces New Netherlands Distribution Hub for VAT-Free EU Business Expansion MIAMI,...
Ascendiant Capital Markets: Society Pass Inc (Nasdaq: SOPA) Reports Strong 2Q 2025 Revenue Growth of 46% Year on Year; IPOs Drive SOPA Valuation
NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Ascendiant Capital Markets LLC (“Ascendiant”) issues equity research report on Society Pass...
REGENXBIO Announces Completion of Enrollment in Pivotal Trials of Subretinal Surabgene Lomparvovec for Wet AMD
Over 1,200 participants enrolled in ATMOSPHERE® and ASCENT® pivotal trials, representing largest global gene therapy program ever conducted Subretinal surabgene...